BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 6184567)

  • 1. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists: a potent vasodilatory principle and alternative basic antihypertensive therapy].
    Bolli P; Erne P; Bühler FR
    Schweiz Med Wochenschr; 1983 Nov; 113(46):1733-5. PubMed ID: 6658418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
    G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension with calcium antagonists.
    Murphy MB
    Int J Clin Pharmacol Res; 1985; 5(5):287-91. PubMed ID: 2866165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrochlorothiazide is not additive to verapamil in treating essential hypertension.
    Nicholson JP; Resnick LM; Laragh JH
    Arch Intern Med; 1989 Jan; 149(1):125-8. PubMed ID: 2643413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists in the treatment of arterial hypertension. Attempt at a differential therapy].
    Kiowski W
    Fortschr Med; 1984 Jul; 102(27-28):721-4. PubMed ID: 6479815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of a patient with hypertension].
    Martynov IV; Popov VG; Martynov AI
    Klin Med (Mosk); 1984 Mar; 62(3):135-44. PubMed ID: 6143852
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiovascular regulation as a function of age. Determinants of antihypertensive treatment based on beta-blockers and calcium inhibitors].
    Bühler FR
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():83-90. PubMed ID: 2868700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration and antihypertensive effect of slow-release verapamil.
    Schütz E; Ha HR; Bühler FR; Follath F
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S346-9. PubMed ID: 6184566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers.
    Massie BM
    Am J Cardiol; 1985 Dec; 56(16):97H-100H. PubMed ID: 2866709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy.
    Erne P; Bolli P; Bürgisser E; Bühler FR
    N Engl J Med; 1984 Apr; 310(17):1084-8. PubMed ID: 6143260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonism--a new concept for treating essential hypertension.
    Müller FB; Bolli P; Erne P; Kiowski W; Bühler FR
    Am J Cardiol; 1986 Feb; 57(7):50D-53D. PubMed ID: 3006467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological hypertension therapy].
    Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
    Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.